Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

HuMax-CD20 in Chronic Lymphocytic Leukemia

This study has been withdrawn prior to enrollment.
(Acquired asset)
Sponsor:
Information provided by:
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00093314
First received: October 6, 2004
Last updated: April 20, 2015
Last verified: January 2007
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: January 2007
  Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):